dr mascarenhas discusses mds/mpn overlap for patients
Published 5 years ago • 900 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
1:37
dr. mascarenhas on the potential role of pacritinib in mpns
-
2:00
dr. mascarenhas on approved and emerging treatment options in myelofibrosis
-
1:38
dr. mascarenhas on the need to develop curative therapies in myelofibrosis
-
4:53
what questions should patients ask about mpn test results?
-
10:41
myelodysplastic syndrome (mds) - what is the treatment?
-
4:04
which tests do you need following an mpn diagnosis?
-
1:47
the evolution of myelofibrosis treatment and modern-day management
-
6:55
diagnostic challenges: when is it mds?
-
15:18
myelodysplastic syndrome (mds)
-
4:36
living in the moment with myelofibrosis—david’s mf journey
-
39:56
mast cell activation syndrome (mcas): symptoms, diagnosis and treatment made simple by dr. rajsree
-
4:06
what is mds (myelodysplastic syndrome)?
-
28:38
quality of life as treatment goal in mds
-
1:31:23
mds classification & prognosis
-
0:56
john mascarenhas, md, on the individualized management of myeloproliferative neoplasms
-
6:17
classification and prognosis in mds
-
3:37
what is mds or myelodysplastic syndrome?
-
4:10
who criteria and diagnosis in mds
-
5:52
improving quality of life and survival in patients with mds
-
7:13
the broad spectrum of mds
-
1:06
john mascarenhas, md, on the role of molecular analysis in myeloproliferative neoplasms
-
1:14
john mascarenhas, md, on jak inhibitors & combination therapies in myeloproliferative neoplasms